Randox Licenses sPLA2 CVD Risk Test from Aterovax

Product News   May 02, 2013

 
Randox Licenses sPLA2 CVD Risk Test from Aterovax
FURTHER INFORMATION
 

This content appears on:

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Related Product News

Improved Pipetting Performance for Biobanking and Diagnostics

Product News

Tecan’s new wide bore disposable tip is ideal for biobanking and clinical applications.

READ MORE

Versatile and Silent Recapper for High DNA Sample Throughput

Product News

RadboudUMC has reported on its effective use of the Micronic Univo Screw Cap Recapper SR096 to securely seal its valuable DNA samples.

READ MORE

Beckman Invests in UK Microbiology Market

Product News

Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics and MicroScan Microbiology Systems.

READ MORE